QIAGEN® is the leading global provider of sample and assay technologies and has one of the broadest panels of molecular diagnostic tests available worldwide.
QIAGEN provides a modern solution for infectious disease testing: QuantiFERON® technology, a method for detecting cell-mediated immune (CMI) responses in whole blood samples.
QuantiFERON-TB Gold (QFT®) is a simple blood test that accurately assists the identification of people infected with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Testing for TB is important for those most at risk, such as patients taking immunosuppressive therapy, people living with HIV/AIDS, healthcare workers, people from and travelers to countries with high TB infection rates, and those who have been in close contact with active TB disease.
Visit www.QuantiFERON.com to learn more about QuantiFERON technology and view product updates, latest news, and more.
For a listing of over 800 published, peer-reviewed clinical references, please visit QIAGEN’s comprehensive resource for information relating to QuantiFERON-TB Gold, Gnowee™, on www.gnowee.net.